Effect of a dominant negative ras on myocardial hypertrophy by using adenoviral-mediated gene transfer

Surgery

Volumn 122, Issue 2, 1997, Pages 404-411

  Pracyk, John B ^a   Hegland, Donald D ^a   Tanaka, Koichi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; ENDOTHELIN; MITOGEN ACTIVATED PROTEIN KINASE; PHALLOIDIN;

ADENOVIRUS; ANIMAL TISSUE; CLONING VECTOR; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; HEART VENTRICLE HYPERTROPHY; MORPHOLOGY; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0030870338     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90033-7     Document Type: Conference Paper

References (18)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990;322:1561-6.
2. Bogoyevitch MA, Sugden PH. The role of protein kinases in adaptational growth of the heart. Int J Biochem Cell Biol 1996;28:1-12.
3. Lembo G, Huhter JJ, Chien KR. Signaling pathways for cardiac growth and hypertrophy: recent advances and prospects for growth factor therapy. Ann N Y Acad Sci 1995;752:115-27.
4. Satoh T, Nakfuku M, Kaziro Y. Function of ras as a molecular switch in signal transduction. J Biol Chem 1992;267:24149-52.
5. Lassar AB, Thayer MJ, Overell RW, Weintraub H. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 1989;58:659-67.
6. Thorburn A, Thornburn J, Chen S, Powers S, Shubeita H, Feramisco J, et al. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J Biol Chem 1993;268:2244-9.
7. Thorburn A. RAS activity is required for phenylephrine-induced activation of mitogen-activated protein kinase in cardiac muscle cells. Biochem Biophys Res Commun 1994;205:1417-22.
8. Sadoshima J, Izumo S. The heterotrimeric G protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 1996;15:775-87.
9. Feig L, Cooper G. Inhibition of NIH3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 1988;8:3235-43.
10. Chinnadurai G, Chinnadurai S, Brusca J. Physical mapping of a large-plaque mutation of adenovirus type 2. J Virol 1979;32:623-8.
11. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adeovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 1994;91:10732-6.
12. 2 for platelet-derived growth factor signal transduction. Science 1995;270:296-9.
13. Thorburn J, Frost JA, Thorburn A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol 1994;126:1565-72.
14. Marshall CJ. Ras effectors. Curr Opin Cell Biol 1996;8:197-204.
15. 1-adrenergic stimulation. J Biol Chem 1994;269:13490-6.
16. Zou Y, Komuro I, Yamazaki T, et al. Protein kinase C, but not tyrosine kinases or ras, plays a critical role in angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J Biol Chem 1996;271:33592-7.
17. Ridley AJ. Rho-related proteins: actin cytoskeleton and cell cycle. Curr Opin Genet Dev 1995;5:24-30.
18. 1-adrenergic receptor signaling in cardiomyocytes. J Biol Chem 1996;271:31185-90.